A Multi-Stakeholder Lung Cancer Study That Uncovered Hidden Tumors and Achieved FDA Approval

The objective was to provide intra-operative identification of cancer cells using a novel imaging system. This system incorporated a special camera, and a folate analog combined with a fluorescent dye, enabling surgeons to visualize tumours not detectable by the naked eye or standard imaging methods.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution

17th February 2026 to 17th February 2026

02/10/2026

Caidya Strengthens European Growth Strategy and Appoints Mario Bautista as Head of Business Development, Europe

RALEIGH, N.C.; Feb 10, 2026 – Caidya, a leading global, mid-sized CRO focused on accelerating...

12/19/2025

Caidya’s Miles Pan Named to Legal 500 GC Powerlist China 2025

RALEIGH, N.C. and SHANGHAI, CHINA; December 19, 2025 – Caidya,...
Skip to toolbar